ahlam1399
08-01-2016, 06:47 PM
Keryx withdraws 2016 forecast on renal drug supply disruption
(Reuters) - Keryx Biopharmaceuticals Inc said it was withdrawing its full-year forecast due to issues related to the production of its only approved drug, Auryxia.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=spwvwGv7vTE:9nnLaBjaIYU:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=spwvwGv7vTE:9nnLaBjaIYU:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=spwvwGv7vTE:9nnLaBjaIYU:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=spwvwGv7vTE:9nnLaBjaIYU:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=spwvwGv7vTE:9nnLaBjaIYU:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/spwvwGv7vTE
(Reuters) - Keryx Biopharmaceuticals Inc said it was withdrawing its full-year forecast due to issues related to the production of its only approved drug, Auryxia.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=spwvwGv7vTE:9nnLaBjaIYU:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=spwvwGv7vTE:9nnLaBjaIYU:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=spwvwGv7vTE:9nnLaBjaIYU:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=spwvwGv7vTE:9nnLaBjaIYU:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=spwvwGv7vTE:9nnLaBjaIYU:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/spwvwGv7vTE